These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8878387)

  • 1. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
    Imagawa DK; Dawson S; Holt CD; Kirk PS; Kaldas FM; Shackleton CR; Seu P; Rudich SM; Kinkhabwala MM; Martin P; Goldstein LI; Murray NG; Terasaki PI; Busuttil RW
    Transplantation; 1996 Oct; 62(7):934-42. PubMed ID: 8878387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.
    Katznelson S; Wilkinson AH; Kobashigawa JA; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Cohen AH; Teraski PI
    Transplantation; 1996 May; 61(10):1469-74. PubMed ID: 8633373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients.
    Penson MG; Fricker FJ; Thompson JR; Harker K; Williams BJ; Kahler DA; Schowengerdt KO
    J Heart Lung Transplant; 2001 Jun; 20(6):611-8. PubMed ID: 11404165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin on outcomes after cardiac transplantation.
    Kobashigawa JA; Katznelson S; Laks H; Johnson JA; Yeatman L; Wang XM; Chia D; Terasaki PI; Sabad A; Cogert GA
    N Engl J Med; 1995 Sep; 333(10):621-7. PubMed ID: 7637722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats.
    Kakkis JL; Ke B; Dawson S; Maggard M; Si M; Kaldas F; Cai W; Shau H; Seu P; Sauri H; Busuttil RW; Imagawa DK
    J Surg Res; 1997 May; 69(2):393-8. PubMed ID: 9224413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders.
    Murdock DK; Murdock AK; Murdock RW; Olson KJ; Frane AM; Kersten ME; Joyce DM; Gantner SE
    Am Heart J; 1999 Jul; 138(1 Pt 1):151-5. PubMed ID: 10385779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
    Zachoval R; Gerbes AL; Schwandt P; Parhofer KG
    J Hepatol; 2001 Jul; 35(1):86-91. PubMed ID: 11495047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Utility of pravastin in cardiac transplant dyslipidemia].
    Martínez-Dolz L; Almenar Bonet L; Arnau Vives MA; Rueda Soriano J; Osa Sáez A; Dicenta Gisbert F; Palencia Pérez M
    Rev Clin Esp; 2002 Sep; 202(9):489-91. PubMed ID: 12236939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pravastatin on hyperlipidemia in renal transplant recipients.
    Yoshimura N; Oka T; Okamoto M; Ohmori Y
    Transplantation; 1992 Jan; 53(1):94-9. PubMed ID: 1733092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation.
    Demetriou D; Shabpar A; Böhmig G; Schmaldienst S; Hörl WH; Watschinger B
    Wien Klin Wochenschr; 2000 Apr; 112(8):358-61. PubMed ID: 10849941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 14. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
    Vaessen LM; van Miert PP; van Gelder T; Ijzermans JN; Weimar W
    Transplantation; 2001 Apr; 71(8):1175-9. PubMed ID: 11374422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
    J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with low-dose pravastatin and fish oil in post-renal transplantation dislipidemia.
    Grekas D; Kassimatis E; Makedou A; Bacharaki D; Bamichas G; Tourkantonis A
    Nephron; 2001 Aug; 88(4):329-33. PubMed ID: 11474227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The West of Scotland Coronary Prevention Study: a trial of cholesterol reduction in Scottish men.
    Shepherd J
    Am J Cardiol; 1995 Sep; 76(9):113C-117C. PubMed ID: 7572679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK; Mak TW; Chan TH; Wang A; Lam CW; Lai KN
    Transplantation; 1995 Oct; 60(7):652-6. PubMed ID: 7570971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.